PURPOSE: To estimate the current cancer burden in Korea, newly diagnosed cancer cases and cancer incidence rates were calculated for the years 2003~2005. MATERIALS AND METHODS: The cancer incidence cases and rates were calculated from the Korea National Cancer Incidence Database. Crude and age-standardized incidence rates were calculated by gender for specified cancer sites in 5-year age groups. RESULTS: From 2003 to 2005, 398,824 cases of cancer were newly diagnosed in Korea (218,856 in men and 179,968 in women). For all sites combined, the crude incidence rate (CR) was 300.0 and 248.2 for men and women and the age-standardized incidence rate (ASR) was 297.0 and 191.2 per 100,000, respectively. Among men, five leading cancers were stomac...
BACKGROUND: Prostate cancer (PCa) is the second most frequently diagnosed cancer in male. In South K...
Existing epidemiologic reports or studies of cancer statistics in Korea lack sufficient data on canc...
Background: In South Korea, there have been few nationwide epidemiologic studies about premalignant ...
PURPOSE: We estimated the incidence of cancer in Korea. MATERIALS AND METHODS: The indicence of c...
PURPOSE: This paper overviews the nationwide cancer statistics including incidence, mortality, survi...
PURPOSE: To estimate the current cancer burden in Korea, cancer incidence and mortality were project...
Cancer has been the most common cause of death in Korea since 1983 and is a major public health conc...
Cancer has been the leading cause of death in Korea. Korea is facing a very rapid change and increas...
Objectives: This study aimed to identify the current patterns of cancer incidence and estimate the p...
PURPOSE: This study estimated the economic burden of cancer in Korea during 2000-2010 by cancer site...
PURPOSE: The Korean National Cancer Screening Survey (KNCSS) is a continuous nationwide survey imple...
Background: The purpose of this study was to develop a single measure of cancer burden (SMCB), which...
In Korea, cancer is the third leading cause of death among adolescents and young adults (AYAs). Howe...
Background: In Korea, cancer is the third leading cause of death among adolescents and young adults ...
To figure out the epidemiologic characteristics of cancer in Korea during recent years, changing pa...
BACKGROUND: Prostate cancer (PCa) is the second most frequently diagnosed cancer in male. In South K...
Existing epidemiologic reports or studies of cancer statistics in Korea lack sufficient data on canc...
Background: In South Korea, there have been few nationwide epidemiologic studies about premalignant ...
PURPOSE: We estimated the incidence of cancer in Korea. MATERIALS AND METHODS: The indicence of c...
PURPOSE: This paper overviews the nationwide cancer statistics including incidence, mortality, survi...
PURPOSE: To estimate the current cancer burden in Korea, cancer incidence and mortality were project...
Cancer has been the most common cause of death in Korea since 1983 and is a major public health conc...
Cancer has been the leading cause of death in Korea. Korea is facing a very rapid change and increas...
Objectives: This study aimed to identify the current patterns of cancer incidence and estimate the p...
PURPOSE: This study estimated the economic burden of cancer in Korea during 2000-2010 by cancer site...
PURPOSE: The Korean National Cancer Screening Survey (KNCSS) is a continuous nationwide survey imple...
Background: The purpose of this study was to develop a single measure of cancer burden (SMCB), which...
In Korea, cancer is the third leading cause of death among adolescents and young adults (AYAs). Howe...
Background: In Korea, cancer is the third leading cause of death among adolescents and young adults ...
To figure out the epidemiologic characteristics of cancer in Korea during recent years, changing pa...
BACKGROUND: Prostate cancer (PCa) is the second most frequently diagnosed cancer in male. In South K...
Existing epidemiologic reports or studies of cancer statistics in Korea lack sufficient data on canc...
Background: In South Korea, there have been few nationwide epidemiologic studies about premalignant ...